<Disease><Name>XANTHINURIA TYPE II</Name><Synonym>XANTHINE DEHYDROGENASE AND ALDEHYDE OXIDASE, COMBINED DEFICIENCY OF</Synonym><OMIM><Number>603592</Number><URL>http://omim.org/entry/603592</URL></OMIM><Orphanet><Number>93602</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=93602</URL></Orphanet><Protein><Number>Xanthine dehydrogenase/oxidase</Number><URL>http://www.uniprot.org/uniprot/Q96EN8</URL></Protein><ExPASy><Number>1.17.1.4</Number><URL>http://enzyme.expasy.org/EC/1.17.1.4</URL></ExPASy><Gene>18q12.2</Gene><ICD>E79.8</ICD><Summary>rare ;autosomal recessive;2 types: ;- Type I Xanthine oxidoreductasen (OMIM 378300);- Type II Xanthine oxidoreductase and aldehyde oxidase (OMIM 603592)</Summary><Symptoms><symtomp><id>2019</id><symptom>hair, abnormal  (thin, brittle, fine)</symptom><category>SKIN</category></symtomp><symtomp><id>2619</id><symptom>hydronephrosis</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2275</id><symptom>infections (urinary tract)</symptom><category>GENITOURINARY TRACT | IMMUNE OR HEMATOLOGIC SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1786</id><symptom>myopathy</symptom><category>MUSCLES</category></symtomp><symtomp><id>1922</id><symptom>nephrocalcinosis</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>1717</id><symptom>no clinical symptoms (probably) / no clinical  significance</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2554</id><symptom>onset, fetus / fetal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3783</id><symptom>onset, variable age</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2122</id><symptom>renal cysts</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>4101</id><symptom>renal failure, acute</symptom><category /></symtomp><symtomp><id>1859</id><symptom>Teeth: generalized defect or abnormalities</symptom><category>HEAD</category></symtomp><symtomp><id>2236</id><symptom>urolithiasis, nephrolithiasis, kidney stones</symptom><category>GENITOURINARY TRACT</category></symtomp></Symptoms><Metabolites><metabolite><id>1536</id><name>Hypoxanthine</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>88.10</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>1537</id><name>Hypoxanthine</name><specimen>urine</specimen><value>increased</value><min>1.80</min><max>24.10</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1068</id><name>Hypoxanthine</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>71.90</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>HPLC</method><comment /></metabolite><metabolite><id>1067</id><name>Hypoxanthine</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>10.00</max><unit>&#956;mol/l</unit><age>all</age><method /><comment /></metabolite><metabolite><id>1996</id><name>Hypoxanthine</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>71.90</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>451</id><name>Uric acid</name><specimen>urine</specimen><value>decreased</value><min>527.00</min><max>790.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>1535</id><name>Uric acid</name><specimen>urine</specimen><value>decreased</value><min>222.00</min><max>287.00</max><unit>mmol/mol creatinine</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>776</id><name>Uric acid</name><specimen>urine</specimen><value>decreased</value><min>820.00</min><max>1026.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>417</id><name>Uric acid</name><specimen>serum</specimen><value>decreased</value><min>120.00</min><max>350.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>1555</id><name>Xanthine</name><specimen>urine</specimen><value>increased</value><min>20.00</min><max>70.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>4984</id><title>Mutations associated with functional disorder of xanthine oxidoreductase and hereditary xanthinuria in humans</title><author>Ichida K,</author><journal>nt J Mol Sci</journal><year>2012</year><book /><volume>13</volume><number>11</number><pages>15475-95</pages><co_aut>et al.</co_aut></literature><literature><id>1470</id><title>Hereditary xanthinuria type II associated with mental delay, autism, cortical renal cysts, nephrocalcinosis, osteopenia, and ha</title><author>Zannolli R</author><journal>J Med Genet</journal><year>2003</year><book /><volume>40</volume><number>11</number><pages>121</pages><co_aut>et al.</co_aut></literature><literature><id>1471</id><title>Identification of a new point mutation in the human molybdenum cofactor sulferase gene that is responsible for xanthinuria type</title><author>Yamamoto T</author><journal>Metabolism</journal><year>2003</year><book /><volume>52</volume><number>11</number><pages>1501-1504</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>